Latest News for: hbv

Edit

Precision BioSciences Presents Preclinical Safety and Efficacy Data Supporting Repeat Dosing of PBGENE-HBV With a ...

Business Wire 20 Mar 2025
... supporting repeat dosing of PBGENE-HBV in the ELIMINATE-B trial to treat patients with chronic HBV.
  • 1
×